SMTL ID : 6mej.1

Crystal structure of Hepatitis C virus envelope glycoprotein E2 ectodomain in complex with human antibodies HEPC3 and HEPC46

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.80 Å
Oligo State
hetero-1-1-1-1-1-mer
Ligands
1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose
1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Flyak, A.I. et al., HCV Broadly Neutralizing Antibodies Use a CDRH3 Disulfide Motif to Recognize an E2 Glycoprotein Site that Can Be Targeted for Vaccine Design. Cell Host Microbe (2018)
Release Date
2018-11-21
Peptides
antibody HEPC46 Heavy Chain: A
antibody HEPC46 Light Chain: B
E2 glycoprotein: C
antibody HEPC3 Heavy Chain: D
antibody HEPC3 Light Chain: E
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
H
E
L

antibody HEPC46 Heavy Chain

antibody HEPC46 Light Chain

E2 glycoprotein

antibody HEPC3 Heavy Chain

antibody HEPC3 Light Chain

Related Entries With Identical Sequence

6med.1 | 6med.2 | 6med.3 | 6meg.1 | 6mei.1 | 6mek.1 | 6mek.2 | 7u0b.1 | 7u0c.1 | 7u0c.2 | 7u0c.3